COVID19, a virus responsible for the current global pandemic, belongs to the coronaviruses group. Coronaviruses have several unique features. For instance, their genome is composed of RNA, not DNA.
Also, the RNA of coronaviruses is unusually long compared to other organisms.
Studying the features of the new virus in detail is crucial for developing therapies against it. Unfortunately, most researchers focus on the proteins that the virus produces, as those proteins interact with our cells and produce the actual damage.
Still, would it not be more productive to prevent making those dangerous proteins in the first place?
To do this, two research teams, one from Cambridge and another from Justus Liebig University, Giessen, Germany, have focused their study on the large RNA genome of the virus and how it interacts with cellular machinery.
In a regular cell, the RNA is used as a direct template for the production of proteins. A specialized structure from the cell called a ribosome participates in this process. In the case of coronaviruses, the RNA genome is used both to produce proteins and make smaller RNAs that participate in regulation. The main RNA genome can form complex structures with those smaller RNAs and the distant regions of the primary genome itself. The research team has developed a new method called COMRADES that allows seeing these interactions in detail. Scientists have found that in SARS-COV-2, the RNA genome forms a specialized structure that allows the ribosome to skip the “stop ” signal on the RNA. This leads to making proteins that can be different in length and function. This way, a coronavirus can change its properties without changing its actual genome. If this structure is disrupted, the virus becomes less virulent. This discovery is crucial for understanding the new coronavirus’s properties and understanding similar viruses better. The authors are also hopeful their discovery can help with possible antiviral therapies.
Sources
Reference : “The Short- and Long-Range RNA-RNA Interactome of SARS-CoV-2: Molecular Cell” . Accessed August 14, 2021. Link .